• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, September 13, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Biologists find mechanisms that control where transcription factors bind

Bioengineer by Bioengineer
May 15, 2018
in Cancer
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A team of biologists has determined how transcription factors (TFs), which guide gene regulation, function differently in embryonic development. The results help illuminate how cells acquire distinct functions as the embryo matures.

"The basic principles learned from these findings are important in understanding how the activities of transcription factors control development of higher organisms, including mice and humans," observes Stephen Small, a professor in New York University's Department of Biology and one of the researchers. "More specifically, the results offer a potential pathway to better grasp how mutated genes that interfere with transcription factors can cause profound disruptions in embryonic development and result in a range of diseases, including cancer."

The study, which is reported in the journal Genes & Development, also included scientists from Harvard Medical School and Johns Hopkins University.

Biologists have historically had difficulty precisely understanding how transcription factors control embryo development. This is because they number in the hundreds and different combinations are expressed in individual cell types as development proceeds.

Moreover, studies have produced conflicting results. For example, in previous biochemical experiments, researchers have shown that individual TFs within a family bind to the same DNA sequence; but, genetic experiments have revealed that they have very different activities in the cells of a developing embryo.

"Thus, the rules that determine where a specific TF will bind within an organism, and consequently which target genes it will activate, are still unclear," explains Small.

In the Genes & Development study, led by Rhea Datta, a postdoctoral fellow at NYU's Center for Developmental Genetics, the scientists examined two similar TFs (Bicoid [Bcd] and Orthodenticle [Otd]) in the fruit fly Drosophila that were previously shown to bind a common DNA sequence (TAATCC).

They directly mapped the genomic regions that Bcd and Otd bind to in the embryo and showed that some regions are bound by both proteins while others are bound only by Bcd or Otd. They further showed that each protein prefers to bind sequences that differ by only a single base from the TAATCC common sequence. Finally, binding by Bcd occurred only in genomic regions containing binding sites for two other TFs that may facilitate Bcd binding.

The data, the researchers conclude, identified a precise DNA "sequence code" that controls how TFs function correctly in specifying cell fates within a living embryo.

###

The research was supported by grants from the National Institutes of Health (RO1 HG005287, GM106090).

Media Contact

James Devitt
[email protected]
212-998-6808
@nyuniversity

https://www.nyu.edu/about/news-publications/news.h

Share12Tweet7Share2ShareShareShare1

Related Posts

FBXW11 Ubiquitinates YB1, Suppressing Hepatocarcinoma Growth

September 13, 2025

Advancing Liver Transplantation for Cancer with Genomics

September 13, 2025

Tumor Microenvironment Dynamics in Breast Cancer Therapy

September 13, 2025

Blocking Tumors: PD-L1 siRNA Boosts Immunotherapy

September 13, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    153 shares
    Share 61 Tweet 38
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    116 shares
    Share 46 Tweet 29
  • Physicists Develop Visible Time Crystal for the First Time

    65 shares
    Share 26 Tweet 16
  • A Laser-Free Alternative to LASIK: Exploring New Vision Correction Methods

    49 shares
    Share 20 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Boosting Xanthan Gum Production with Essential Oil By-products

Groundwater Pesticide Contamination: Challenges and Solutions

FBXW11 Ubiquitinates YB1, Suppressing Hepatocarcinoma Growth

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.